Doctor profile · Federal record
Dr. Thomas O'Connell, MD
Endocrinology, Diabetes & Metabolism Physician (CMS: Endocrinology) · Burlington, NC
- NPI 1710047311
- Accepts Medicare
- 31 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
1234 Huffman Mill Road
Burlington, NC 272158700
(336) 538-1234
fax (335) 584-6811
Credentials & registration
- NPI registered
- December 2006 — 20 yrs on file
- Profile last updated
- March 16, 2020
- Year of graduation
- 1995 — 31 yrs since
- Specialty taxonomy
- 207RE0101X — NUCC code
- State license (1)
- North Carolina #9800991
- Medicaid
- NC #8911620
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1710047311. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
6,308
Distinct HCPCS
10
Medicare allowed
$191,028
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J0897 |
Injection, denosumab, 1 mg | 3,960 | 43 | $23 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 560 | 335 | $119 | |
36415 |
Insertion of needle into vein for collection of blood sample | 315 | 217 | $8 | |
83036 |
Hemoglobin a1c level | 304 | 180 | $9 | |
84443 |
Blood test, thyroid stimulating hormone (tsh) | 189 | 147 | $16 | |
77080 |
Dxa bone density measurement of hip, pelvis, spine | 180 | 180 | $15 | |
95251 |
Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 151 | 72 | $32 | |
J3489 |
Injection, zoledronic acid, 1 mg | 100 | 20 | $9 | |
80048 |
Blood test, basic group of blood chemicals (calcium, total) | 74 | 63 | $8 | |
96372 |
Injection of drug or substance under skin or into muscle | 74 | 47 | $13 |
In context: peer comparison
Among 2 peers in this city , average services per provider: 324. This provider delivers 19× the peer median.Open Payments
Industry payments received
All-time total
$112,397
Transactions
246
Manufacturers
12
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Insulet Corporation | 77 | $38,959.82 | |
| Lilly USA, LLC | 85 | $32,364.25 | |
| SANOFI-AVENTIS U.S. LLC | 21 | $22,485.59 | |
| Novo Nordisk Inc | 43 | $18,186.25 | |
| Abbott Laboratories | 10 | $139.32 | |
| Dexcom, Inc. | 1 | $94.92 | |
| Radius Health, Inc. | 2 | $51.58 | |
| Ancora Heart, Inc. | 2 | $37.05 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $28.28 | |
| Ascensia Diabetes Care Us Inc. | 1 | $18.93 | |
| Xeris Pharmaceuticals, Inc. | 1 | $17.68 | |
| CeQur Corporation | 1 | $13.75 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
4,437
Patients
1,074
Total drug cost
$2,341,951
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ozempic (Semaglutide) | Brand | 566 | 98 | $654,957 |
| Levothyroxine Sodium | Generic | 516 | 150 | $8,602 |
| Jardiance (Empagliflozin) | Brand | 439 | 76 | $343,339 |
| Metformin Hcl | Generic | 415 | 122 | $4,694 |
| Trulicity (Dulaglutide) | Brand | 349 | 64 | $482,494 |
| Metformin Hcl Er (Metformin Hcl) | Brand | 314 | 91 | $5,444 |
| Lantus Solostar (Insulin Glargine,hum.Rec.Anlog) | Brand | 261 | 65 | $170,110 |
| Pioglitazone Hcl | Generic | 255 | 70 | $4,470 |
| Glimepiride | Generic | 250 | 77 | $3,684 |
| Rosuvastatin Calcium | Generic | 248 | 70 | $4,602 |
Frequently asked questions
What is Dr. Thomas O'Connell's medical specialty?
Dr. Thomas O'Connell practices Endocrinology, Diabetes & Metabolism Physician in Burlington, NC.
Where does Dr. Thomas O'Connell practice?
Dr. Thomas O'Connell practices at 1234 Huffman Mill Road, Burlington, NC 272158700. Office phone: 3365381234.
What is Dr. Thomas O'Connell's NPI?
Dr. Thomas O'Connell's National Provider Identifier (NPI) is 1710047311, issued by NPPES.
Does Dr. Thomas O'Connell accept Medicare assignment?
Yes. Dr. Thomas O'Connell accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Thomas O'Connell commonly perform?
Top Medicare-reported procedures in 2023: Injection, denosumab, 1 mg (HCPCS J0897); Established patient office or other outpatient visit (HCPCS 99214); Insertion of needle into vein for collection of blood sample (HCPCS 36415). Source: CMS Medicare Physician & Other Practitioners file.